Nuvectis Pharma, Inc. (NVCT)
23.92
+0.86
(+3.73%)
USD |
NASDAQ |
Sep 02, 16:00
24.00
+0.08
(+0.33%)
After-Hours: 20:00
Nuvectis Pharma Cash from Operations (Annual) : -16.01M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -16.01M |
| December 31, 2024 | -12.25M |
| December 31, 2023 | -15.95M |
| Date | Value |
|---|---|
| December 31, 2022 | -13.56M |
| December 31, 2021 | -9.504M |
| December 31, 2020 | 0.00 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Decoy Therapeutics, Inc. | -4.827M |
| Unicycive Therapeutics, Inc. | -31.32M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |